Search Results

The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Dainippon Sumitomo Pharma Co Ltd -Company Report'
Title Publication Date Price Relevance
Dainippon Sumitomo Pharma Co. Ltd: PharmaVitae Model Jan 2009 £3,605 100%
Dainippon Sumitomo Pharma Co., Ltd.-Detailed Product Pipeline Mar 2011 £475 99%
Dainippon Sumitomo Pharma Co., Ltd.-Therapeutic Competitors Report Mar 2011 £220 99%
Dainippon Sumitomo Pharma Co., Ltd.-Deals & Alliances Report Mar 2011 £380 99%
Dainippon Sumitomo Pharma Co., Ltd. – Product Pipeline Review
H2 2011
 Nov 2011 £315 98%
The Pharmaceutical Market: Japan Oct 2011 £595 85%
Ono Pharmaceutical Co., Ltd. – Product Pipeline Review
H2 2011
 Nov 2011 £315 79%
Diabetic Neuropathy - Pipeline Review
H2 2011
 Oct 2011 £315 78%
Bipolar Disorder Jun 2010 £2,500 78%
Bronchitis Global Clinical Trials Review
H2 2011
 Oct 2011 £630 76%
Overactive Bladder Global Clinical Trials Review
Q2, 2011
 Jun 2011 £630 76%
Liver Cirrhosis Global Clinical Trials Review
H2, 2011
 Sep 2011 £630 76%
Insomnia Global Clinical Trials Review
H2, 2011
 Dec 2011 £630 76%
Meningitis Global Clinical Trials Review
H2, 2011
 Nov 2011 £630 75%
Neuralgia - Pipeline Review
H2 2011
 Nov 2011 £315 75%
Sleep Disorders Global Clinical Trials Review
H2, 2011
 Nov 2011 £630 75%
Respiration Disorders Global Clinical Trials Review
Q1, 2011
 Jan 2011 £630 74%
Migraine - Pipeline Review
H2 2011
 Sep 2011 £315 74%
Schizophrenia Global Clinical Trials Review
H2 2011
 Oct 2011 £630 74%
Sleep Disorders - Pipeline Review
H1 2012
 Jan 2012 £325 74%
Diabetic Neuropathy Global Clinical Trials Review
Q2, 2011
 Jun 2011 £630 74%
Depression - Pipeline Review
H2 2011
 Aug 2011 £315 73%
Hyperlipidemia - Pipeline Review
H2 2011
 Aug 2011 £315 73%
Schizophrenia - Pipeline Review
H2 2011
 Sep 2011 £315 73%
Allergic Rhinitis - Pipeline Review
H2 2011
 Sep 2011 £315 73%
Rhinitis - Pipeline Review
H2 2011
 Sep 2011 £315 73%
Parkinson's Disease Global Clinical Trials Review
H2 2011
 Oct 2011 £630 73%
Obstructive Pulmonary Disease Global Clinical Trials Review
Q1, 2011
 Jan 2011 £630 73%
Asthma Global Clinical Trials Review
H2, 2011
 Dec 2011 £630 73%
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review
H2, 2011
 Dec 2011 £630 73%